Topics

Orphan Drug Designation granted for AZ’ Imfinzi

07:56 EDT 12 Jul 2019 | PharmaTimes

The decision comes hot on the heels of the Phase III CASPIAN trial, which met its primary endpoint.

Original Article: Orphan Drug Designation granted for AZ’ Imfinzi

NEXT ARTICLE

More From BioPortfolio on "Orphan Drug Designation granted for AZ’ Imfinzi"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...